OTCMKTS:ORINY Orion OYJ (ORINY) Stock Price, News & Analysis $37.29 0.00 (0.00%) As of 10/3/2025 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort InterestBuy This Stock About Orion OYJ Stock (OTCMKTS:ORINY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Orion OYJ alerts:Sign Up Key Stats Today's Range$37.29▼$37.2950-Day Range$36.40▼$41.4852-Week Range$21.95▼$41.60Volume102 shsAverage Volume431 shsMarket Capitalization$10.53 billionP/E Ratio25.37Dividend Yield0.91%Price TargetN/AConsensus RatingHold Company Overview Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research. Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France. The company’s R&D organization focuses on novel chemical entities and life-cycle management of existing products, supported by a network of research partnerships and licensing agreements. In addition to human healthcare, Orion Diagnostica develops and distributes immunoassays and point-of-care tests for clinical and veterinary diagnostics. Orion serves markets across Europe, the Nordic countries and selected regions in Asia and Latin America, leveraging both direct sales operations and partner networks. The company maintains strategic alliances to expand its geographic reach and enhance market access for its specialty products. Orion’s customer base includes hospitals, pharmacies and healthcare professionals, reflecting its long-established presence in the pharmaceutical industry.AI Generated. May Contain Errors. Read More Receive ORINY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orion OYJ and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ORINY Stock News HeadlinesHere is Why Growth Investors Should Buy Orion OYJ (ORINY) NowJuly 28, 2025 | msn.comLooking for a Growth Stock? 3 Reasons Why Orion OYJ (ORINY) is ... - NasdaqJuly 13, 2025 | nasdaq.comNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 trillion calculations per second. Elon Musk and Nvidia’s Jensen Huang are now teaming up to deploy one million of these chips inside what could become the most advanced AI machine on the planet. But according to James Altucher, the real opportunity isn’t in Tesla or Nvidia. He’s uncovered a little-known company that Musk, Nvidia, and even 98% of the Fortune 500 already rely on to make AI 2.0 possible. Nvidia’s CEO has even called this company “essential” to their expansion. | Paradigm Press (Ad)Recent Price Trend in Orion OYJ (ORINY) is Your Friend, Here's WhyJuly 11, 2025 | msn.comLooking for a Growth Stock? 3 Reasons Why Orion OYJ (ORINY) is a Solid ChoiceJuly 11, 2025 | msn.comEuropean Dividend Stocks To Consider In April 2025April 25, 2025 | finance.yahoo.comOrion Oyj (ORINY) Q1 2025 Earnings Call Highlights: Strong Growth in Net Sales and Operating ProfitApril 24, 2025 | gurufocus.comOrion Group Interim Report January–March 2025April 23, 2025 | finance.yahoo.comSee More Headlines ORINY Stock Analysis - Frequently Asked Questions How have ORINY shares performed this year? Orion OYJ's stock was trading at $21.95 at the start of the year. Since then, ORINY stock has increased by 69.9% and is now trading at $37.29. How were Orion OYJ's earnings last quarter? Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) announced its earnings results on Friday, July, 18th. The company reported $0.33 earnings per share for the quarter. The company had revenue of $472.57 million for the quarter. Orion OYJ had a trailing twelve-month return on equity of 38.68% and a net margin of 22.61%. How do I buy shares of Orion OYJ? Shares of ORINY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings7/18/2025Today10/06/2025Ex-Dividend for 11/7 Dividend10/16/2025Record date for 11/7 Dividend10/17/2025Next Earnings (Estimated)11/04/2025Dividend Payable11/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryN/A Current SymbolOTCMKTS:ORINY Previous SymbolNASDAQ:ORINY CIKN/A Webwww.orion.fi Phone358 10 4261FaxN/AEmployees3,712Year FoundedN/AProfitability EPS (Trailing Twelve Months)$1.47 Trailing P/E Ratio25.37 Forward P/E Ratio31.60 P/E GrowthN/ANet Income$356.98 million Net Margins22.61% Pretax Margin28.22% Return on Equity38.68% Return on Assets22.98% Debt Debt-to-Equity Ratio0.15 Current Ratio1.86 Quick Ratio1.05 Sales & Book Value Annual Sales$1.67 billion Price / Sales6.31 Cash Flow$1.62 per share Price / Cash Flow23.01 Book Value$3.85 per share Price / Book9.69Miscellaneous Outstanding Shares282,269,000Free FloatN/AMarket Cap$10.53 billion OptionableNot Optionable Beta0.11 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (OTCMKTS:ORINY) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersThis soon could be the most precious company in AmericaCurrently, a brand-new, all-American factory outside San Antonio is becoming the most significant site in the ...True Market Insiders | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orion OYJ Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Orion OYJ With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.